Abstract
In 2012 CNS & Neurological Disorders - Drug Targets will enter its 11th year of publication. This year will also mark my third year as Editor-in-Chief.
Since taking the helm of the journal a number of changes have been introduced, one of my first having been to renew and expand our Editorial Advisory Board to include a broader base of expertise in this incredibly fast-moving area of science.
Starting last year, and continuing in 2012 CNS & Neurological Disorders - Drug Targets expands its production calendar to 8 issues per year, up from the previous frequency of 6 issues. Other developments, which I believe will strengthen interest in the journal and encourage an increasingly diverse range of topic submissions is the inclusion, apart from reviews, of both full-length and letter-type research articles as well as clinical case reports. We have added also sections dealing with short Research Highlights discussing recent, high impact publications of relevance to the journal's mission together with reports on meetings.
A number of cutting-edge Hot Topic issues are in the works for 2012, including nanoneuroscience, endocannabinoids, novel strategies for neuropsychiatric disorders, and purinergic receptor signaling. CNS & Neurological Disorders - Drug Targets is always open to theme issue proposals from our readers, and I encourage you to submit your ideas for consideration.
With best wishes for a productive New Year,
CNS & Neurological Disorders - Drug Targets
Title:Message from the Editor-in-Chief
Volume: 11 Issue: 1
Author(s): Stephen D. Skaper
Affiliation:
Abstract:
In 2012 CNS & Neurological Disorders - Drug Targets will enter its 11th year of publication. This year will also mark my third year as Editor-in-Chief.
Since taking the helm of the journal a number of changes have been introduced, one of my first having been to renew and expand our Editorial Advisory Board to include a broader base of expertise in this incredibly fast-moving area of science.
Starting last year, and continuing in 2012 CNS & Neurological Disorders - Drug Targets expands its production calendar to 8 issues per year, up from the previous frequency of 6 issues. Other developments, which I believe will strengthen interest in the journal and encourage an increasingly diverse range of topic submissions is the inclusion, apart from reviews, of both full-length and letter-type research articles as well as clinical case reports. We have added also sections dealing with short Research Highlights discussing recent, high impact publications of relevance to the journal's mission together with reports on meetings.
A number of cutting-edge Hot Topic issues are in the works for 2012, including nanoneuroscience, endocannabinoids, novel strategies for neuropsychiatric disorders, and purinergic receptor signaling. CNS & Neurological Disorders - Drug Targets is always open to theme issue proposals from our readers, and I encourage you to submit your ideas for consideration.
With best wishes for a productive New Year,
Export Options
About this article
Cite this article as:
Stephen D. Skaper , Message from the Editor-in-Chief, CNS & Neurological Disorders - Drug Targets 2012; 11 (1) . https://dx.doi.org/10.2174/187152712799960763
DOI https://dx.doi.org/10.2174/187152712799960763 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Techniques of Drug Repurposing: Delivering a new life to Herbs & Drugs
Of late, with the adaptation of innovative approaches and integration of advancements made towards medical sciences as well as the availability of a wide range of tools; several therapeutic challenges are being translated into viable clinical solutions, with a high degree of efficacy, safety, and selectivity. With a better understanding ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Single Dose Pharmacokinetics of Metoclopramide Oral Tablets Utilizing HPLC-UV Method
Current Pharmaceutical Analysis May Adjuvant Therapy Play A Role for the Management of Renal Cell Carcinoma? A Review of Literature and Ongoing Trials
Anti-Cancer Agents in Medicinal Chemistry Pathogenic Mechanisms and Therapeutic Strategies in Spinobulbar Muscular Atrophy
CNS & Neurological Disorders - Drug Targets Erythropoietin and Oxidative Stress
Current Neurovascular Research Effects of Atorvastatin on Cerebral Blood Flow in Middle-Aged Adults at Risk for Alzheimer’s Disease: A Pilot Study
Current Alzheimer Research “Nutritional Psychiatry: Evidence of the Role of Foods in Mental Health” Part 1
Current Pharmaceutical Biotechnology Editorial [ Hot Topic:Endocannabinoid-Binding Receptors: Old Friends and New Comers (Guest Editor: Mauro Maccarrone)]
Current Medicinal Chemistry Cigarette Smoking, Metabolic Activation and Carcinogenesis
Current Drug Metabolism Current Problems, New Opportunities and Future Directions of Antiplatelet Therapy - Increasing Role of Novel Antiplatelet Agents in Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Functional Cell-Based Assays in Microliter Volumes for Ultra-High Throughput Screening
Combinatorial Chemistry & High Throughput Screening Vitamin D, Sunlight, and the Epidemiology of Prostate Cancer
Anti-Cancer Agents in Medicinal Chemistry Molecular Modeling of Human Hepatocyte PKA (cAMP-Dependent Protein Kinase Type-II) and Its Structure Analysis
Protein & Peptide Letters From Nature to Market: Examples of Natural Products that Became Drugs
Recent Patents on Biotechnology Neuroprotective Role of Nanoparticles Against Alzheimer's Disease
Current Drug Metabolism Cardiovascular Risk Calculators and their Applicability to South Asians
Current Diabetes Reviews The Expression of Activity-Dependent Neuroprotective Protein (ADNP) is Regulated by Brain Damage and Treatment of Mice with the ADNP Derived Peptide, NAP, Reduces the Severity of Traumatic Head Injury
Current Alzheimer Research Polypharmacy in Cardiovascular Medicine: Problems and Promises!
Cardiovascular & Hematological Agents in Medicinal Chemistry Revisiting the Medical Management of Parkinson’s Disease: Levodopa versus Dopamine Agonist
Current Neuropharmacology Antibodies Against Complement System in SLE and their Potential Diagnostic Utility
Current Rheumatology Reviews Psychoimmunological Analysis of Cancer Patients: Correlation with the Prognosis
Current Aging Science